Quent Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Quent Capital's PFE Position: Q1 2026 in Review
Quent Capital increased its Pfizer (PFE) stake by 17% in Q1 2026, buying an estimated $59.6K and bringing the position to 15,691 shares worth $441K. The position accounts for 0.03% of the portfolio, ranked #227.
Quent Capital first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $921K in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Quent Capital held 15,691 shares of Pfizer worth $441K as of Q1 2026.
- Quent Capital bought 2,238 Pfizer shares in Q1 2026, an estimated $59.6K.
- Pfizer made up 0.03% of Quent Capital's portfolio in Q1 2026, its #227 holding.
- Quent Capital first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Quent Capital's Pfizer position peaked at $921K in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.